Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

268 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Early specific cognitive-behavioural psychotherapy in subjects at high risk for bipolar disorders: study protocol for a randomised controlled trial.
Pfennig A, Leopold K, Bechdolf A, Correll CU, Holtmann M, Lambert M, Marx C, Meyer TD, Pfeiffer S, Reif A, Rottmann-Wolf M, Schmitt NM, Stamm T, Juckel G, Bauer M. Pfennig A, et al. Among authors: holtmann m. Trials. 2014 May 8;15:161. doi: 10.1186/1745-6215-15-161. Trials. 2014. PMID: 24886581 Free PMC article. Clinical Trial.
Efficacy of cognitive-behavioral group therapy in patients at risk for serious mental illness presenting with subthreshold bipolar symptoms: Results from a prespecified interim analysis of a multicenter, randomized, controlled study.
Leopold K, Bauer M, Bechdolf A, Correll CU, Holtmann M, Juckel G, Lambert M, Meyer TD, Pfeiffer S, Kittel-Schneider S, Reif A, Stamm TJ, Rottmann-Wolf M, Mathiebe J, Kellmann EL, Ritter P, Krüger-Özgürdal S, Karow A, Sondergeld LM, Roessner V, Sauer C, Pfennig A. Leopold K, et al. Among authors: holtmann m. Bipolar Disord. 2020 Aug;22(5):517-529. doi: 10.1111/bdi.12894. Epub 2020 Mar 13. Bipolar Disord. 2020. PMID: 32112496 Clinical Trial.
Individualised short-term therapy for adolescents impaired by attention-deficit/hyperactivity disorder despite previous routine care treatment (ESCAadol)-Study protocol of a randomised controlled trial within the consortium ESCAlife.
Geissler J, Jans T, Banaschewski T, Becker K, Renner T, Brandeis D, Döpfner M, Dose C, Hautmann C, Holtmann M, Jenkner C, Millenet S, Romanos M. Geissler J, et al. Among authors: holtmann m. Trials. 2018 Apr 27;19(1):254. doi: 10.1186/s13063-018-2635-2. Trials. 2018. PMID: 29703226 Free PMC article.
Individualised stepwise adaptive treatment for 3-6-year-old preschool children impaired by attention-deficit/hyperactivity disorder (ESCApreschool): study protocol of an adaptive intervention study including two randomised controlled trials within the consortium ESCAlife.
Becker K, Banaschewski T, Brandeis D, Dose C, Hautmann C, Holtmann M, Jans T, Jendreizik L, Jenkner C, John K, Ketter J, Millenet S, Pauli-Pott U, Renner T, Romanos M, Treier AK, von Wirth E, Wermter AK, Döpfner M. Becker K, et al. Among authors: holtmann m. Trials. 2020 Jan 9;21(1):56. doi: 10.1186/s13063-019-3872-8. Trials. 2020. PMID: 31918739 Free PMC article.
268 results